Apogee Therapeutics, Inc. Conversion of Stock, Shares Converted
Apogee Therapeutics, Inc. (APGE) reported Conversion of Stock, Shares Converted of 72.64 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2026-08-10
- Apogee Therapeutics, Inc. conversion of stock, shares converted for the quarter ending 2024-12-31 was 65.88K shares, a 0.00% change year-over-year.
- Apogee Therapeutics, Inc. conversion of stock, shares converted for the quarter ending 2023-12-31 was 65.88K shares.
- Apogee Therapeutics, Inc. conversion of stock, shares converted for fiscal 2025 was 72.64M shares, a 0.00% change from fiscal 2024.
- Apogee Therapeutics, Inc. conversion of stock, shares converted for fiscal 2024 was 72.64M shares, a 0.00% change from fiscal 2023.
- Apogee Therapeutics, Inc. conversion of stock, shares converted for fiscal 2023 was 72.64M shares.
| Period end | Conversion of Stock, Shares Converted | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|
| 2025-12-31 | 72.64M shares 10-K · filed 2026-03-02 | |||
| 2024-12-31 | 65.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 72.64M shares 10-K · filed 2026-03-02 | ||
| 2024-09-30 | 72.57M shares 10-Q · filed 2024-11-12 | |||
| 2023-12-31 | 65.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 72.64M shares 10-K · filed 2026-03-02 | ||
| 2023-09-30 | 72.57M shares 10-Q · filed 2024-11-12 | |||
| 2023-07-18 | 24.99M shares 10-Q · filed 2026-08-10 |